Obesity, exceptionally prevalent in the USA, promotes the incidence and progression of
numerous cancer types including breast cancer. Complex, interacting metabolic and …

Previous evidence on postdiagnosis body fatness and mortality after breast cancer was
graded as limited‐suggestive. To evaluate the evidence on body mass index (BMI), waist …

Metabolic syndrome is a type of multifactorial metabolic disease with the presence of at least
three factors: obesity, diabetes mellitus, low high-density lipoprotein, hypertriglyceridemia …

Background Adiposity and weight change among patients with breast cancer are associated
with mortality, but there is limited evidence on the associations with distant recurrence or …

Despite the existence of extensive clinical research and novel therapeutic treatments,
cancer remains undefeated and the significant cause of death worldwide. Cancer is a …

Objective To explore the effects of metabolic syndrome (MetS) on the prognosis of
endometrial cancer (EC) and to identify key components of MetS associated with EC …

Breast cancer is the most common and second deadliest malignancy in women. With rising
obesity rates and building evidence for a strong association with obesity, the incidence of …

The increased deposition of visceral fat in the postmenopause period increases the
production of inflammatory cytokines and the release of tumor necrosis factor-α (TNF-α) …

Obesity and metabolic disorders have been associated with poor outcomes in non-
Mediterranean breast cancer (BC) patients. The purpose of this study was to investigate the …

Background This research delved into the association between the risk of the Chinese
population suffering from breast cancer (BC) and the triglyceride-glucose (TyG) index …